BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siokas V, Tsouris Z, Aloizou AM, Bakirtzis C, Liampas I, Koutsis G, Anagnostouli M, Bogdanos DP, Grigoriadis N, Hadjigeorgiou GM, Dardiotis E. Multiple Sclerosis: Shall We Target CD33? Genes (Basel) 2020;11:E1334. [PMID: 33198164 DOI: 10.3390/genes11111334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Siokas V, Aloizou AM, Tsouris Z, Liampas I, Liakos P, Calina D, Docea AO, Tsatsakis A, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson's Disease. J Clin Med 2021;10:381. [PMID: 33498513 DOI: 10.3390/jcm10030381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Bogdanos DP, Baloyannis SJ, Dardiotis E. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci 2022. [PMID: 35258237 DOI: 10.1515/revneuro-2021-0148] [Reference Citation Analysis]
3 Siokas V, Arseniou S, Aloizou AM, Tsouris Z, Liampas I, Sgantzos M, Liakos P, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. CD33 rs3865444 as a risk factor for Parkinson's disease. Neurosci Lett 2021;748:135709. [PMID: 33582190 DOI: 10.1016/j.neulet.2021.135709] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Siokas V, Katsiardanis K, Aloizou AM, Bakirtzis C, Liampas I, Koutlas E, Rudolf J, Ntinoulis K, Kountouras J, Dardiotis E, Deretzi G. Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study. Neurol Int 2021;13:517-26. [PMID: 34698268 DOI: 10.3390/neurolint13040051] [Reference Citation Analysis]
5 Aloizou AM, Siokas V, Pateraki G, Liampas I, Bakirtzis C, Tsouris Z, Lazopoulos G, Calina D, Docea AO, Tsatsakis A, Bogdanos DP, Dardiotis E. Thinking outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke. J Clin Med 2021;10:630. [PMID: 33562264 DOI: 10.3390/jcm10040630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Aloizou AM, Pateraki G, Anargyros K, Siokas V, Bakirtzis C, Liampas I, Nousia A, Nasios G, Sgantzos M, Peristeri E, Dardiotis E. Transcranial magnetic stimulation (TMS) and repetitive TMS in multiple sclerosis. Rev Neurosci 2021. [PMID: 33641274 DOI: 10.1515/revneuro-2020-0140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]